MED

SEC source: 0001104659-21-081619 · tm2119857d1_4seq1.xml · nonDerivative · entry 11

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,254

F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on March 2, 2021.

F12 · price: This transaction was executed in multiple trades at prices ranging from $282.00 USD to $282.10 USD inclusive; the price reported above reflects theweighted average sale price.

SEC source: 0001104659-21-081619 · tm2119857d1_4seq1.xml · nonDerivative · entry 10

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,557

F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on March 2, 2021.

F11 · price: This transaction was executed in multiple trades at prices ranging from $281.00 USD to $281.94 USD inclusive; the price reported above reflects theweighted average sale price.

SEC source: 0001104659-21-081619 · tm2119857d1_4seq1.xml · nonDerivative · entry 9

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,595

F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on March 2, 2021.

F10 · price: This transaction was executed in multiple trades at prices ranging from $279.85 USD to $280.83 USD inclusive; the price reported above reflects theweighted average sale price.

SEC source: 0001104659-21-081619 · tm2119857d1_4seq1.xml · nonDerivative · entry 8

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,502

F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on March 2, 2021.

F9 · price: This transaction was executed in multiple trades at prices ranging from $278.85 USD to $279.84 USD inclusive; the price reported above reflects theweighted average sale price.

SEC source: 0001104659-21-081619 · tm2119857d1_4seq1.xml · nonDerivative · entry 7

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,769

F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on March 2, 2021.

F8 · price: This transaction was executed in multiple trades at prices ranging from $277.85 USD to $278.83 USD inclusive; the price reported above reflects theweighted average sale price.

SEC source: 0001104659-21-081619 · tm2119857d1_4seq1.xml · nonDerivative · entry 6

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,290

F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on March 2, 2021.

F7 · price: This transaction was executed in multiple trades at prices ranging from $292.67 USD to $293.32 USD inclusive; the price reported above reflects theweighted average sale price.

SEC source: 0001104659-21-081619 · tm2119857d1_4seq1.xml · nonDerivative · entry 5

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,690

F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on March 2, 2021.

F6 · price: This transaction was executed in multiple trades at prices ranging from $291.30 USD to $291.74 USD inclusive; the price reported above reflects theweighted average sale price.

SEC source: 0001104659-21-081619 · tm2119857d1_4seq1.xml · nonDerivative · entry 4

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,891

F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on March 2, 2021.

F5 · price: This transaction was executed in multiple trades at prices ranging from $290.25 USD to $291.16 USD inclusive; the price reported above reflects theweighted average sale price.

SEC source: 0001104659-21-081619 · tm2119857d1_4seq1.xml · nonDerivative · entry 3

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,652

F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on March 2, 2021.

F4 · price: This transaction was executed in multiple trades at prices ranging from $288.92 USD to $289.88 USD inclusive; the price reported above reflects theweighted average sale price.

SEC source: 0001104659-21-081619 · tm2119857d1_4seq1.xml · nonDerivative · entry 2

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,215

F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on March 2, 2021.

F3 · price: This transaction was executed in multiple trades at prices ranging from $287.86 USD to $288.53 USD inclusive; the price reported above reflects the weighted average sale price.

SEC source: 0001104659-21-081619 · tm2119857d1_4seq1.xml · nonDerivative · entry 1

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,479

F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on March 2, 2021.

F2 · price: This transaction was executed in multiple trades at prices ranging from $286.86 USD to $287.85 USD inclusive; the price reported above reflects theweighted average sale price.

SEC source: 0001104659-21-077873 · tm2119051-7_4seq1.xml · derivative · entry 1

Xian Ming · CIK 0001743879 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,751

Underlying: Common Stock · 630 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents the right to receive 630 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Directors' Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 3, 2022. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock.

F1 · derivative.exercise_date: Represents the right to receive 630 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Directors' Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 3, 2022. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock.

F1 · derivative.expiration_date: Represents the right to receive 630 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Directors' Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 3, 2022. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock.

SEC source: 0001104659-21-077872 · tm2119051-6_4seq1.xml · nonDerivative · entry 1

Thomas Andrea B · CIK 0001779769 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,790

F1 · shares: Represents the right to receive 659 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Directors' Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 3, 2022.

SEC source: 0001104659-21-077871 · tm2119051-5_4seq1.xml · nonDerivative · entry 1

SCHLACKMAN SCOTT · CIK 0001645617 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,900

F1 · shares: Represents the right to receive 669 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Directors' Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 3, 2022.

SEC source: 0001104659-21-077870 · tm2119051-4_4seq1.xml · nonDerivative · entry 1

Hoer Michael A. · CIK 0001743755 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,780

F1 · shares: Represents the right to receive 650 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Directors' Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 3, 2022.

SEC source: 0001104659-21-077869 · tm2119051-3_4seq1.xml · nonDerivative · entry 1

HALLQUIST CONSTANCE J. · CIK 0001645615 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,984

F1 · shares: Represents the right to receive 679 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Directors' Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 3, 2022.

SEC source: 0001104659-21-077868 · tm2119051-2_4seq1.xml · nonDerivative · entry 1

BYRNES KEVIN G · CIK 0001224725 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,827

F1 · shares: Represents the right to receive 650 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Directors' Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 3, 2022.

SEC source: 0001104659-21-077867 · tm2119051-1_4seq1.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,735

F1 · shares: Represents the right to receive 765 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Directors' Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 3, 2022.

SEC source: 0001104659-21-087804 · tm2121193-1_4aseq1.xml · nonDerivative · entry 1

SCHLACKMAN SCOTT · CIK 0001645617 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,804

F1 · balance_after: On June 7, 2021, the reporting person filed a Form 4 which inadvertently did not reflect the sale of 96 shares of common stock that was previously reported on a Form 4 filed on May 21, 2021. As reported in this amendment, the reporting person beneficially owns 5,804 shares of common stock.

SEC source: 0001104659-21-070571 · tm2117278-1_4seq1.xml · nonDerivative · entry 2

SCHLACKMAN SCOTT · CIK 0001645617 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,135

SEC source: 0001104659-21-070571 · tm2117278-1_4seq1.xml · nonDerivative · entry 1

SCHLACKMAN SCOTT · CIK 0001645617 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,231

SEC source: 0001104659-21-064073 · tm2115816-1_4.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Brown Equity Partners, LLC

Disclosed balance after: 28,645.105

F1 · kind: The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member, pursuant to a broker-sponsored Dividend Reinvestment Plan.

SEC source: 0001104659-21-039261 · tm2110392d3_4.xml · nonDerivative · entry 1

Johnson Stephen Kyle · CIK 0001803048 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 665

F1 · shares: Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

SEC source: 0001104659-21-039260 · tm2110392d2_4.xml · nonDerivative · entry 1

Maloney James P. · CIK 0001715428 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,968

F1 · shares: Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

SEC source: 0001104659-21-039259 · tm2110392d1_4.xml · nonDerivative · entry 1

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,326

F1 · shares: Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

SEC source: 0001104659-21-032841 · tm218878d1_4.xml · derivative · entry 5

HALLQUIST CONSTANCE J. · CIK 0001645615 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

Underlying: Common Stock · 2,000 shares

Expires 2026-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options vested in three equal annual installments beginning on February 4, 2017.

SEC source: 0001104659-21-032841 · tm218878d1_4.xml · derivative · entry 4

HALLQUIST CONSTANCE J. · CIK 0001645615 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires 2025-09-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options vested in three equal annual installments beginning on September 15, 2016.

SEC source: 0001104659-21-032841 · tm218878d1_4.xml · nonDerivative · entry 3

HALLQUIST CONSTANCE J. · CIK 0001645615 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,305

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.631 to $259.440, inclusive.

SEC source: 0001104659-21-032841 · tm218878d1_4.xml · nonDerivative · entry 2

HALLQUIST CONSTANCE J. · CIK 0001645615 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,805

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-21-032841 · tm218878d1_4.xml · nonDerivative · entry 1

HALLQUIST CONSTANCE J. · CIK 0001645615 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,805

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-21-026923 · tm217757d2_4.xml · nonDerivative · entry 2

Chard Daniel R · CIK 0001289557 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,831

SEC source: 0001104659-21-026923 · tm217757d2_4.xml · nonDerivative · entry 1

Chard Daniel R · CIK 0001289557 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,140

SEC source: 0001104659-21-026922 · tm217757d1_4.xml · nonDerivative · entry 1

Johnson Stephen Kyle · CIK 0001803048 · VP, Finance & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 393

SEC source: 0001104659-21-016821 · tm216005-1_4.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Brown Equity Partners, LLC

Disclosed balance after: 28,465.486

F1 · kind: The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member, pursuant to a broker-sponsored Dividend Reinvestment Plan.

SEC source: 0001104659-21-011819 · tm215332-1_4seq1.xml · nonDerivative · entry 1

BYRNES KEVIN G · CIK 0001224725 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,177

SEC source: 0001104659-20-123683 · tm2035627d1_4.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Brown Equity Partners, LLC

Disclosed balance after: 28,332.636

F1 · kind: The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member, pursuant to a broker-sponsored Dividend Reinvestment Plan.

SEC source: 0001104659-20-111796 · tm2032380d1_4.xml · nonDerivative · entry 5

MACDONALD MICHAEL C · CIK 0001207400 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,179

F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.07 to $167.21, inclusive.

SEC source: 0001104659-20-111796 · tm2032380d1_4.xml · nonDerivative · entry 4

MACDONALD MICHAEL C · CIK 0001207400 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,362

F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.00 to $166.89, inclusive.

SEC source: 0001104659-20-111796 · tm2032380d1_4.xml · nonDerivative · entry 3

MACDONALD MICHAEL C · CIK 0001207400 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,986

F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.01 to 165.99, inclusive.

SEC source: 0001104659-20-111796 · tm2032380d1_4.xml · nonDerivative · entry 2

MACDONALD MICHAEL C · CIK 0001207400 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 269,770

F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.00 to 164.99, inclusive.

SEC source: 0001104659-20-111796 · tm2032380d1_4.xml · nonDerivative · entry 1

MACDONALD MICHAEL C · CIK 0001207400 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 271,002

F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.02 to $163.86, inclusive.

SEC source: 0001104659-20-094009 · tm2027430d1_4.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Brown Equity Partners, LLC

Disclosed balance after: 28,134.407

F1 · kind: The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member, pursuant to a broker-sponsored Dividend Reinvestment Plan.

SEC source: 0001104659-20-085707 · tm2025382d2_4.xml · nonDerivative · entry 1

Maloney James P. · CIK 0001715428 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,192

F1 · shares: Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

SEC source: 0001104659-20-085708 · tm2025382-3_4.xml · nonDerivative · entry 1

SASSANO CARL E · CIK 0001225020 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,199

SEC source: 0001104659-20-083165 · tm2024772-1_4.xml · nonDerivative · entry 2

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Brown Equity Partners, LLC

Disclosed balance after: 27,959.523

F1 · kind: The reporting person transferred these shares to Brown Equity Partners, LLC, for which the reporting person is the managing member.

SEC source: 0001104659-20-083165 · tm2024772-1_4.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,970

F1 · kind: The reporting person transferred these shares to Brown Equity Partners, LLC, for which the reporting person is the managing member.

SEC source: 0001104659-20-081282 · tm2024193d2_4.xml · nonDerivative · entry 1

HALLQUIST CONSTANCE J. · CIK 0001645615 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,305

F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 19, 2019.

SEC source: 0001104659-20-081283 · tm2024193d3_4.xml · derivative · entry 1

Xian Ming · CIK 0001743879 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,121

Underlying: Common Stock · 1,083 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents an annual grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in full on June 30, 2021. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock on the date of vesting.

F1 · derivative.exercise_date: Represents an annual grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in full on June 30, 2021. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock on the date of vesting.

F1 · derivative.expiration_date: Represents an annual grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in full on June 30, 2021. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock on the date of vesting.

SEC source: 0001104659-20-081280 · tm2024193d1_4.xml · nonDerivative · entry 9

MACDONALD MICHAEL C · CIK 0001207400 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 271,179

F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.00 to $142.62, inclusive.

SEC source: 0001104659-20-081280 · tm2024193d1_4.xml · nonDerivative · entry 8

MACDONALD MICHAEL C · CIK 0001207400 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 271,739

F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 12, 2019.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.00 to $141.99, inclusive.